Back

Prior fecal immunochemical test positivity is associated with adverse prognosis in patients with acute ST-segment elevation myocardial infarction

1 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: New considerations in acute coronary syndromes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Wenbo Dai

2nd Hospital of Tianjin Medical University, Tianjin (China)

8 More presentations in this session

Presentation thumbnail
Pre-discharge prediction of long-term prognosis in patients after ST-segment elevation myocardial infarction - the ValAMI-P risk score
Doctor H. Merenciano Gonzalez (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
An examination of co-existence of metabolic dysfunction-associated liver disease and chronic kidney disease and its effect on long-term mortality in patients with acute myocardial infarction
Doctor A. Zhang (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland
Doctor A. Bularga (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
The prognostic value of metabolic dysfunction associated steatotic liver disease in acute myocardial infarction
Doctor G. Kong (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Iron deficiency and all-cause mortality after myocardial infarction
Doctor D. Jenca (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
New considerations in acute coronary syndromes

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block
thumbnail
Congress Presentation
Prognostic significance of clonal haematopoiesis of indeterminate potential-mutations with inflammation biomarkers in patients with STEMI
thumbnail
Congress Presentation
Predictors of new cancer diagnosis following a NSTEMI event: insights from a national cancer registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources